Inventor · disambiguated record
Csanad M. Varga
Also filed as: VARGA CSANAD · VARGA CSANAD M
9 granted patents·22 pending applications·110 citations·filing 2009–2025
90Inventor score
Top patents by PatentIndex Score
31 records- 0195US11560434B2Formulation for anti-α4β7 antibodyMILLENNIUM PHARM INC·Filed 2020·Granted Jan 24, 2023·7 cites·33 claims
- 0295US8859504B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2012·Granted Oct 14, 2014·29 cites·15 claims
- 0394US9764033B2Formulation for anti-α4β7 antibodyDILUZIO WILLOW·Filed 2012·Granted Sep 19, 2017·32 cites·33 claims
- 0492US9175018B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2014·Granted Nov 3, 2015·12 cites·40 claims
- 0591US11485746B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2020·Granted Nov 1, 2022·2 cites·14 claims
- 0691US2025041424A1Methods for treatment using anti-alpha4beta7 antibodyTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0790US10040855B2Formulation for anti-α4β7 antibodyDILUZIO WILLOW·Filed 2012·Granted Aug 7, 2018·19 cites·29 claims
- 0890US2025000981A1Methods for treatment using anti-alpha4beta7 antibodyTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0987US9175017B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2014·Granted Nov 3, 2015·5 cites·13 claims
- 1087US2023265111A1Boronate ester compounds and pharmaceutical compositions thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1187US2025034263A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2024·Application pending·0 cites
- 1286US10604538B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2019·Granted Mar 31, 2020·2 cites·1 claims
- 1386US10526351B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2019·Granted Jan 7, 2020·2 cites·1 claims
- 1486US2025295786A1Methods for treatment using anti-alpha4beta7 antibodyTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 1581US2022370617A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2022·Application pending·0 cites
- 1680US2022009948A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 1780US2023312727A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2022·Application pending·0 cites
- 1878US2021198289A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 1976US2020392164A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 2074US2020181176A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 2172US2019263839A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2019·Application pending·0 cites
- 2271US2019231878A1Formulation for anti-alpha4beta7 antibody and methods of treatmentMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 2371US2019048028A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 2470US2009325903A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 2569US2018208609A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 2668US2018002350A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 2767US2019076532A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 2863US2018346578A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 2963US2018327497A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 3062US2016031913A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2015·Application pending·0 cites
- 3150US2023203009A1Pralsetinib pharmaceutical compositionsBLUEPRINT MEDICINES CORP·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →